2020 Volume 22 Issue 5 Published: 28 May 2020
  

  • Select all
    |
  • Abstract ( ) PDF ( )
     A small amount of commonly used and first-aid drugs stored in the inpatient wards can facilitate the temporary treatment of patients and save precious time for the treatment of critically ill patients. But there is a risk of medication errors in the link of drug storage in the inpatient wards. In order to strengthen the management of drug storage in the inpatient wards and reduce medication errors, experts in medicine, pharmacy, nursing, hospital management, and etc., were organized by Medication Safety Panel in China Core Group of International Network for the Rational Use of Drugs, Chinese Pharmacological Society Professional Committee of Drug-induced Diseases, and Adverse Drug Reactions Journal Agency, to formulate the guideline for prevention of medication errors in the link of drug storage in inpatient wards based on the Expert Consensus on Medication Error Management in China. The medication errors in the link of drug storage in the inpatient wards include improper storage of drugs, wrong drug specifications, wrong drug quantity, and wrong drug placement. The risk factors include management factors (unsound management system, no designated person or post management, or no regular inspections and supervision), process factors (no corresponding standard operation process, or only imperfect or unreasonable operation process), environmental factors (unqualified drug storage space and equipment, or no special labels), human factors (no training for personnel involved in drug use, or unreasonable staff arrangement), and drug factors (too many types and quantity of drugs in inpatient wards). The prevention strategies include technical strategies (enforcement and constraint management policies, implement of informatization and intelligence management, and formulation of standardized marks and processes, and establishment of standard catalog list and audit project list) and management strategies (establishment of management systems, provision of sufficient human resources, and enhancement of training).
  • Li Tianzuo
    Abstract ( ) PDF ( )
    Dexamethasidine (DEX) is an alpha-2 adrenoreceptor (α2-AR) agonist, which is not only used in the perioperative period, but also in outpatient examination or treatment. The characteristics and advantages of sedation and hypnosis with DEX are that patients can enter a state similar to natural sleep, which is not only beneficial to improve the sedation effect, but also easy to wake up, and there is little jaw relaxation and no obvious respiratory inhibition. The additional advantages of DEX lie in its function of anti-stress response and potential organ protection and its little influence on cognitive function. The main adverse reactions of DEX were temporary hypertension, hypotension, bradycardia, and so on. Another characteristic of DEX is the relatively slow disappearance of drug effect. Patients may have drowsiness and postural hypotension after operation. It must be noted that DEX cannot be used as an independent anesthetic in general anesthesia to act as the main analgesic and sedative, but only to play an auxiliary role, which depends on the reasonable use and dosage and is not "all" or "none". And the vital signs of patients must be closely monitored during the process of DEX application.
  • Lai Yuan, Zhang Jin, Li Kai
    Abstract ( ) PDF ( )
    Objective To explore the effect and safety of dexmedetomidine with different ways of administration on nerve block anesthesia in elderly patients undergoing untensioned repair of inguinal hernia. Methods The elderly patients who underwent untensioned repair of inguinal hernia in Shenyang Fourth People′s Hospital from June 2017 to June 2019 and met the inclusion criteria were randomly divided into local nerve block by ropivacaine+dexmedetomidine group (local anesthesia group) and local nerve block by ropivacaine+intravenous pumping of dexmedetomidine group (local anesthesia+intravenous pumping group) using random number table. Local anesthesia group: 15-ml of solution obtained by a certain dose of dexmedetomidine (calculated by 1-μg/kg) diluted in a suitable volume of 0.9% sodium chloride injection+15-ml of 0.375% ropivacaine were injected locally among iliohypogastric nerve and ilioinguinal nerve under the guidance of ultrasound, and meanwhile 0.9% sodium chloride injection were pumped intravenously at the speed of 1-ml/(kg·h) until the end of operation. Local anesthesia+intravenous pumping group: a dose of dexmedetomidine (calculated by 1-μg/kg) was intravenous pumped, 30-ml of 0.375% ropivacaine were injected among iliohypogastric nerve and ilioinguinal nerve under the guidance of ultrasound 10-minutes later, and at the same time, dexmedetomidine was pumped intravenously at the speed of 0.25-μg/(kg·h) until the end of operation. The patients′ basic information including sex, age, body weight, body height, grade determined by American Society of Anesthesiologists Physical Status Classification, and the operation time were recorded. The changes of heart rate and mean arterial blood pressure (MAP) at different time points [before anesthesia (T0), anesthesia completion (T1), beginning of operation (T2), 15-minutes after anesthesia (T3), 30-minutes after anesthesia (T4)], the onset and maintenance time of sensory nerve block, the analgesic effect during the operation, the patient analgesia satisfaction score at the 24th hour after operation, the visual analogue scale (VAS) scores at 0, 3rd, 6th, 9th, and 12th hour after operation in resting state, and the occurrence of adverse reactions were compared between the 2 groups. Results The differences of basic information in patients between the 2 groups were not statistically significant (P>0.05 for all). The heart rate of patients at T2 and T3 in the local anesthesia+intravenous pumping group were lower than those in the local anesthesia group [(62.55±5.66) beats/min vs. (76.70±6.47) beats/min, (53.83±5.07) beats/min vs. (74.98±5.40) beats/min, P<0.001 for both]. Intra-group comparison showed that the heart rate of patients at T2 and T3 were lower than that at T0 in the local anesthesia+intravenous pumping group [(62.55±5.66) beats/min vs. (72.50±7.14) beats/min, (53.83±5.07) beats/min vs. (72.50±7.14) beats/min, P<0.001 for both]. The differences of MAP at different time points between the 2 groups and in intra-group comparison were not statistically significant (P>0.05 for all). The onset time of anesthesia in the local anesthesia group was shorter than that in the local anesthesia+ intravenous pumping group [(5.2±1.1) min vs. (12.5±0.7) min, P=0.010], while the maintenance time of anesthesia was longer [(742.5±3.5) min vs. (631.0±1.4) min, P=0.010]. There were 38(95%), 2(5%), and 0(0) patients having good, fine, and bad analgesic effect in the local anesthesia group, and 30(75%), 8(20%), and 2(5%) in the local anesthesia+intravenous pumping group, respectively. The difference of analgesic effect between the 2 groups was statistically significant (χ2=6.541, P=0.038). The patients′ anesthesia satisfaction score at the 24th hour after operation in the local anesthesia group was higher than that in the local anesthesia+intravenous pumping group [(9.5±0.7) vs. (7.0±1.4), P=0.030]. The VAS scores at 0, 3rd, 6th, 9th, and 12th hour after operation in resting state in the local anesthesia+intravenous pumping group were higher than those in the local anesthesia group (P<0.05 for all). Intra-group comparison showed that the VAS scores at the 5 time points above-metioned in the local anesthesia group were no statistically significant (P>0.05 for all), the VAS scores at 9th and 12th hour after operation in the local anesthesia+intravenous pumping group were higher than that at 3rd hour, the differences were statistically significant (P<0.05 for both). The dif- ference of the incidence of adverse reactions after operation between the 2 groups was not statistically significant (χ 2=0.697, P=0.410). Conclusions The analgesic effect of local injection of ropivacaine+dexmedetomidine is better than that of local nerve block of ropivacaine+intravenous pumping of dexmedetomidine. Thus the anesthesia program of local nerve block with ropivacaine+dexmedetomidine is recommended in the elderly patients undergoing untensioned repair of inguinal hernia.
  • Yan Xing, Xu Yuan, Lin Na
    Abstract ( ) PDF ( )
    To observe the influence of intranasal dexmedetomidine premedication on general anesthesia effect and safety in pediatric patients undergoing monocular fundus examination for the first time. Methods Pediatric patients with monocular retinoblastoma (RB) who underwent fundus examination under the general anesthesia for the first time in Beijing Tongren Hospital, Capital Medical University from October 2018 to April 2019 were divided into the dexmedetomidine group and the control group by random number table method, each group comprised 30 cases. Before entering the operating room, the children in the dexmedetomidine group received intranasal dexmedetomidine 2-μg/kg and 0.9% sodium chloride injection 0.02-ml/kg in the control group, respectively. Thirty minutes later, the children were transferred to the operation room. Their heart rate and pulse oximetry saturation (SpO2) were monitored and recorded. The children in the 2 groups were anesthetized with 8% sevoflurane inhaled through a mask and then placed into a laryngeal mask for maintenance anesthesia by inhaling 2%-3% sevoflurane. Spontaneous breathing was retained during the operation. The heart rate and SpO2 before nasal administration drip (T0), 30-minutes after nasal drip (T1), at the time of laryngeal mask placement (T2), at the beginning of operation (T3), and at the time of laryngeal mask removal (T4) and retention time in post anesthesia care unit (PACU) were compared between the patients in the 2 groups. The children′s separation status from parents when entering the operation room were evaluated by the Parental Separation Anxiety Scale (PSAS), the emergence agitation degree in PACU were evaluated by the Pediatric Anesthesia Emergence Delirium (PAED) scale, and the level of sedation of children at consciousness recovery in PACU were evaluated by Ramsay score. Results The differences of children′s general condition, SpO2 at different time points, and the retention time in PACU between the 2 groups were not statistically significant (P>0.05 for all). Except T0, the heart rates at time points of T1-T4 in the dexmedetomidine group were lower than those in the control group, and the differences were statistically significant (P<0.05 for all). Compared with those in the control group, the children in the dexmedetomidine group were more easily separated from their parents when entering the operation room; the PSAS score was lower [(2.40±0.81) vs. (2.93±0.87), P=0.018]; the incidence of restlessness during the consciousness recovery period was lower [ (16.7%, 5/30) vs. (63.3%, 19/30), P<0.001]; Ramsay score was higher [(3.2±0.7) vs. (1.9±0.6), P<0.001]; and PAED score was lower [6 (2, 12) vs. 12 (5, 8), P<0.001]. Conclusions Intranasal dexmedetomidine premedication can reduce children′s anxiety degree of separation from parents when entering the operation room and the incidence of emergence agitation during recovery period after general anesthesia, and did not prolong the retention time in PACU. It is suggested that intranasal dexmedetomidine premedication is effective and safe in general anesthesia for ultra-short daytime ophthalmological ambulatory surgery in children.
  • Zhang Zhicui, Han Zhenhua, Fang Fang, Li Jinchang, Cui Ping, Wei Min, Wang Jing
    Abstract ( ) PDF ( )
    Objective To understand the occurrence of intraoperative memory (dream, halluci- nation, and intraoperative awareness) following anesthesia with propofol and sufentanil and analyze its influen- cing factors in patients undergoing painless curettage of the uterine cavity. Methods The modified Brice questionnaire survey results in patients who underwent painless curettage of the uterine cavity under propofol and sufentanil anesthesia in Shuangqiao Hospital from January 2017 to September 2018 were retrospectively analyzed. The memory of patients from anesthesia induction to consciousness recovery after anesthesia was evaluated, and the incidences of dream, hallucination (including sexual hallucination), and intraoperative awareness were calculated. The possible influencing factors (including age, weight, operation time, initial and total dose of propofol, and total dose of sufentanil) of intraoperative memory after anesthesia with propofol and sufentanil were analyzed using logistic regression method. Results A total of 2-142 patients were enrolled, aged (28.3±7.4) years and weighing (61.8±10.2) kg, with gestational age of (7.8±1.3) weeks and a median operation time of 5 (3-28) min; the initial dose of propofol was (94.1±20.9) mg, with a total dose of (110.0±39.8) mg; the total dose of sufentanil was (9.9±0.4) μg. Among the 2-142 patients, 1-038 (48.5%) had memory from anesthesia induction to consciousness recovery after anesthesia, 1-019 (98.2%) of which were defined as dreams, 19 (1.8%) as hallucinations, and no one had intraoperative awareness. Eleven of 1-038 patients were defined as having sexual hallucinations and the incidence was 0.5%. There was no significant correlation between the occurrence of intraoperative memory and age, weight, operation time, initial dose and total dose of propofol, and total dose of sufentanil (P>0.05 for all). Conclusion The anesthesia of propofol combined with sufentanil may lead to dreams and hallucinations in patients undergoing painless curettage of the uterine cavity, and occurrence of sexual hallucinations should be more paid attention to.
  • Bai Fang, Wang Lihua, Tao Hai, Zhou Xibin, Wang Peng, Wang Fei
    Abstract ( ) PDF ( )
    Objective To explore the clinical characteristics, treatment and prognosis of patients with severe lacrimal duct obstruction caused by tegafur-gimeracil-oteracil potassium (S-1). Methods The medical records and follow-up data of the surgical inpatients with severe lacrimal duct obstruction caused by S-1 in Lacrimal Center of Ophthalmology, the Third Medical Center of Chinese PLA General Hospital from January 2017 to January 2019 were analyzed retrospectively. Results A total of 12 patients were enrolled in this study, including 7 males and 5 females, aged (53±8) years. The time of oral administration of S-1 was (4.1±1.1) months, and the time from the beginning of administration of S-1 to the onset of epiphora symptoms was (53.3±31.2) days. All the 12 patients had binocular diseases (involving 12 cases, 24 eyes) and obstruction of both upper and lower lacrimal canaliculi (involving 48 lacrimal canaliculi). Among the 48 obstructed lacrimal canaliculi, 45 (93.8%) were severe, and 3 (6.2%) were moderate. The 8 lacrimal points of the upper and lower lacrimal canaliculi in both eyes of the 2 patients were completely atresic. In 12 patients, 16 eyes in 8 patients were complicated with complete obstruction of nasolacrimal ducts and 8 eyes in the other 4 patients were complicated with incomplete obstruction of nasolacrimal ducts. Eight patients underwent laser dacryoplasty combined with bicanalicular intubation assisted by lacrimal canaliculus micro-endoscopy. After taking off the tubes, epiphora was relieved in 5 patients but not improved in the other 3 patients. Two patients underwent retrograde exploration to probe canaliculi transdacryocyst combined with bicanalicular intubation. After taking off the tubes, epiphora was relieved. Two patients underwent retrograde exploration to probe canaliculi transdacryocyst combined with dacryocystorhinostomy. After taking off the tubes, epiphora was improved obviously and only slight epiphora was found. Conclusions Severe lacrimal duct obstruction caused by S-1 was characterized by extensive multiple obstruction. Appropriate surgical treatment can improve the symptoms of epiphora in some patients.
  • Li Qiuyue, Sun Wenjuan, Zou Yuzhen, Jiao Lei, Hu Yang
    Abstract ( ) PDF ( )
    Medication Safety Officer Society was established in America in 2013 to emphasize that the Medication Safety Officer (MSO) was an integral part of the healthcare team. After that, some countries in North America and European promulgated a series of drug safety guidelines and protocols through the relevant organizations or agencies, thus to establish the normative work pattern, content, and process of MSO. The MSO plays the role of medication safety leaders, medication safety experts, medication safety program practitioners, medication safety researchers, and medication safety educators. Based on the international MSO mode, our hospital has built up a team consisted of the pharmacy department′s director and clinical pharmacists, which has similar functions in MSO, to be responsible for medication safety of the whole hospital. The team has become the member of Drug Alert Workstation of Beijing Drug Administration. They participate in multidisciplinary drug safety research, analyze the data of Beijing ADR Monitoring Centre, and have improved the drug emergency plan in our hospital. The work mode for drug safety in our hospital include pre-warning, real-time tracking, and post-feedback.
  • Wu Jianbiao, Yu Li
    Abstract ( ) PDF ( )
    An 83-year-old male patient received moxifloxacin hydrochloride (moxifloxacin) 400-mg once daily orally for acute attack of chronic obstructive pulmonary disease. He developed scattered red rashes, accompanied by itching, on his both lower limbs 5 hours after the first dose. Next day, the rashes involved skin on the trunk, and purpura appeared on the multiple skin below the knees. Laboratory tests showed platelet count (PLT) 1×109/L,and thrombocytopenia related to moxifloxacin was considered. Moxi- floxacin was stopped and the treatments including hemostasis, anti-allergy, regulation of immune function, and platelet transfusion were given. On day 2 of drug withdrawal, his PLT was 3×109/L, and on day 4 the PLT was 35×109/L. He was transferred to a superior hospital and received the therapy including anti-immune response, platelet-raising, and hemostasis for 5 days. Then his PLT increased to 244×109/L.
  • Lu Cuicui, Zhang Yahui, Yang Rui, Zhang Wen
    Abstract ( ) PDF ( )
     A 51-year-old male patient received ibuprofen intermittently for loin and leg pain for 4 years and regularly (0.2 g, thrice daily) due to the aggravation of pain for 2 years. Then the patient developed nausea and vomiting. Laboratory tests showed red blood cell count 2.13×1012/L, hemoglobin (Hb) 59-g/L, serum creatinine (Scr) 897-μmol/L, uric acid 457-μmol/L, and urine protein (+). Abdominal CT scan showed that both kidneys were with reduced volume, uneven surface, and papillary calcification. The patient was diagnosed with chronic kidney disease stage 5. It was considered that the patient′s chronic kidney disease might be associated with long-term administration of ibuprofen, according to his medication history and clinical presentations. Ibuprofen was discontinued immediately and the patient was given symptomatic treatments including fasting, temporary hemodialysis via jugular vein cannulation, and remedying anemia. Meanwhile, the efficient vascular access was established for long-term hemodialysis. After 7 days, the patient was fed with liquid diet through nasal feeding tube and no symptoms like abdominal distention, nausea, or vomiting appeared. After 22 days, semi-fluid diet was given. After 27 days, his Scr was 531-mmol/L and Hb was 84-g/L.The patient was told not to take nephrotoxic drugs such as ibuprofen, and if necessary, oral acetaminophen (maximum daily dose ≤ 3 g) and analgesic patches for topical use were recommended.
  • Zhi Yongjin, Zhou Fenfen, Wen mengjing, Wu Zhengdong, Zhu Jianfeng
    Abstract ( ) PDF ( )
    A 69-year-old male patient with peripheral T-cell lymphoma received chemotherapy with intravenous doxorubicin liposome. In the first chemotherapy cycle, no obvious adverse reactions appeared. In the second chemotherapy cycle, the patient developed transient muscle soreness during the IV infusion of doxorubicin liposome. In the third chemotherapy cycle, dexamethasone and chlorphenamine were given to prevent anaphylaxis before doxorubicin liposome treatment and the infusion rate was controlled in a standardized way. However, at about 20-minutes of infusion, the patient developed nausea and vomiting. The infusion of doxorubicin was stopped immediately and replaced by IV infusion of 0.9% sodium chloride injection 250-ml. Then the patient developed facial numbness, laryngeal pain, neck discomfort, and multiple parts of skin rash with pruritus. The electrocardiogram monitoring showed heart rate 130 times/min, blood pressure 80/50-mmHg, and oxygen saturation 0.98. The patient was given oxygen inhalation and in half-lying position following the doctor′s advice, but the patient developed dyspnea, hoarseness, and slurred speech 20-minutes later. Physical examination showed the patient′s tongue was hypertrophic, his neck was swollen and thickened. Acute laryngeal edema induced by doxorubicin liposome was considered. Intravenous injection of dexamethasone 10-mg, IV infusion of 10% calcium gluconate, and aerosol inhalation of budesonide inhalation aerosol were given immediately and about 3 hours later, the symptoms gradually improved. Two days later, the allergic symptoms disappeared.
  • Liu Lanlan, Zhao Juanjuan
    Abstract ( ) PDF ( )
    A 62-year-old female patient received oral aspirin enteric-coated tablets 100-mg once daily, clopidogrel hydrogen sulphate tables 75-mg once daily, metoprolol tartrate tablets 18.75-mg twice daily, and rosuvastatin calcium tablets 10-mg once daily after coronary artery stent implantation regularly according to the doctor′s instructions. Several days later, the patient developed edema of hands and feet from the distal end to the proximal end of the extremities, and he developed facial edema with rash and pruritus at the edema site. After 3 days of antiallergic treatment, there was no obvious regression of edema and new rash. After careful inquiry, the patient said that he always developed edema and increased rash symptoms about 2 hours after taking metoprolol tartrate tablets. After discontinuation of metoprolol tartrate tablets for 1 day, and other drugs were continued to be used, the patient′s edema and rash were relieved on the next day, and the above symptoms reappeared when the drug was used again according to the doctor′s instructions on the same day. When the drug was stopped again, the edema and rash were obviously improved the next day.After 2 days of discontinuation, the patient took metoprolol succinate sustained-release tablets at their own discretion, and still developed edema and rash. After discontinuation of metoprolol succinate sustained-release tablets, the edema and rash disappeared completely 10 days later.
  • Liu Yunxing, Shu Qing, Yang Xian, Yao Yao, Wang Hong, Zhao Cheng, Ge Weihong
    Abstract ( ) PDF ( )
    A 58-year-old female patient received cyclosporine 75-mg twice daily orally for dermatomyositis. Seven days later, the patient developed chest pain and dyspnea suddenly. Her oxygen saturation was 79% and the blood pressure was 190/125-mmHg. Laboratory tests showed her brain natriuretic peptide (BNP) 1 470.0 ng/L. The electrocardiogram showed a tall and sharp T-wave in the precordial lead. Chest X-ray showed enlarged heart shadow and suffused shadow in the right lung. The patient was diagnosed as acute left ventricular failure, which was considered to be related to cyclosporine. Cyclosporine was discontinued immediately. After the treatments with oxygen inhalation and IV infusions of methylprednisolone 80-mg and IV injection of furosemide 80-mg for 8 days, her symptoms improved and the BNP decreased to 318.0 ng/L. Then she received tacrolimus 2-mg twice daily orally for dermatomyositis. On day 2 of dermatomyositis treatment, she felt chest tightness and her BNP increased to 1-010.0 ng/L. Lefe ventricular failure induced by tacrolimus was considered. Tacrolimus was stopped immediately and the symptomatic treatments such as diuresis were given. On day 3 of dermatomyositis withdrawal, her chest tightness disappeared and the BNP decreased to 57.5 ng/L.
  • Ma Jie, Wang Nan, Song Yanqing, Li Yueyang
    Abstract ( ) PDF ( )
    An 8-year-old female patient received meropenem for intracranial infection after brainstem tumor resection for 13 days, but the infection was poorly controlled. Teicolanine was added and the fever was relieved 5 days later. After 2 days of the relief, the patient regained fever (body temperature was up to 39.3-℃), her upper body skin was red with itching, and the skin on the trunk and limbs was scattered with flaky red maculopapular rashes. Routine blood examination showed white blood cell count 1.07×109/L, neutrophils 0.03, and neutrophils count 0.03×109/L. Red man syndrome and neutropenia in the patient was considered. Teicolanine was discontinued and symptomatic treatments were given for 5 days. Her symptoms were not improved. Then meropenem was discontinued for 2 days but her symptoms were also not improved. Due to the infection, meropenem was re-given and methylprednisolone was added. The symptoms of adverse reactions were gradually improved and finally subsided completely and neutropils returned to normal. Then methylprednisolone was stopped. Meropenem was continued for 7 days and the symptoms above did not recur.
  • Xu Huiwei, Wu Haiwen, Xu Yingqing, Yu Haiying, Zhou Yan
    Abstract ( ) PDF ( )
    A 66-year-old female patient received Gukang capsules and Jieguqili pills orally for 11 days for fracture. On day 6 after the drugs withdrawal, she developed weakness, anorexia, and yellow urine. Drugs above-mentioned were re-given and ibuprofen and codeine phosphate tablets were added. Five days later, her symptoms were aggravated. Laboratory tests showed alanine aminotransferase (ALT) 778-U/L, aspartate aminotransferase (AST) 782-U/L, alkaline phosphatase (ALP) 151-U/L, total bilirubin (TBil) 34.3-μmol/L, direct bilirubin (DBil) 24.0-μmol/L, and gamma-glutamyltransferase (γ-GT) 111-U/L. It was considered to be liver injury caused by Gukang capsules, Jieguqili pills, and ibuprofen and codeine phosphate tablets. All drugs above were withdrawn and the liver-protective and anti-jaundice treatments were given. After 21 days, laboratory tests showed ALT 24-U/L, AST 17-U/L, ALP 104-U/L, TBil 13.6-μmol/L, DBil 9.0-μmol/L, and γ-GT 52-U/L.
  • Huang Xiaofang, Gong Lixian, Deng Minjia, Yang Chen
    2020, 22(5): 326-327.
    Abstract ( ) PDF ( )
    An 87-year-old female patient with hypertension was given 3 Suhuang Zhike capsules (0.45 g/capsule) for cough. Half an hour after medication, the patient suddenly developed limbs tremor, accompanied by palpitation and sweating. The symptoms lasted for about 10-minutes and relieved spontaneously. Her blood pressure was 145/79-mmHg. Her nervous system examination showed no abnormality; blood glucose, electrolyte, thyroid function, and liver and kidney function were all normal; and electroencephalogram and cranial computed tomography showed no obvious abnormality. Ephedrine in Suhuang Zhike capsules was considered to be related to her symptoms. The drug was stopped and oral alprazolam 0.4-mg was given twice daily. The symptoms of limbs tremor did not recur in the patient.
  • Su Xiancai, Zhang Mingyuan, Chen Ting,Lai Xiaozheng
    Abstract ( ) PDF ( )
    A 45-year-old female patient received oral methimazole and propylthiouracil for hyperthyroidism. The drug was discontinued 2 weeks later due to methimazole-induced agranulocytosis. About 1 month later, the patient was re-given methimazole 10-mg thrice daily according to the doctor′s instructions and advice. She developed high fever and chills about 2 hours after the first administration and half on after the second administration, respectively, with a maximum body temperature of 39.5-℃. The laboratory tests showed WBC 5.99×109/L, neutrophil 0.91, C-reactive protein 2.3-mg/L, and negative bacterial blood culture. Drug fever caused by methimazole was considered. Methimazole was stopped and symptomatic treatment was given. Four and a half hours later, the patient′s body temperature dropped to 36.5-℃. At 1 year of follow-up, the patient did not take methimazole again, and neither high fever nor chills recurred.